X0306 4 2016-01-08 0 0000059440 VECTOR GROUP LTD VGR 0000898860 FROST PHILLIP MD ET AL 4400 BISCAYNE BOULEVARD SUITE 1500 MIAMI FL 33137 0 0 1 0 0001380896 Frost Gamma Investments Trust 4400 BISCAYNE BOULEVARD SUITE 1500 MIAMI FL 33137 0 0 1 0 0001464124 Frost Nevada Investments Trust 4400 BISCAYNE BOULEVARD SUITE 1500 MIAMI FL 33137 0 0 1 0 Common Stock 4677859 I By Frost Nevada Investments Trust Common Stock 14085808 I By Frost Gamma Investments Trust Common Stock 14068 I By Patricia Frost Put (option to buy) 25.00 2016-01-08 4 S 0 500 3.20 A 2016-01-08 2016-08-19 Common shares 50000 500 I By Frost Gamma Investments Trust Put (option to buy) 22.50 2016-01-08 4 S 0 500 1.75 A 2016-01-08 2016-08-19 Common shares 50000 500 I By Frost Gamma Investments Trust All shares and price information has been adjusted to reflect the 5% stock dividend, which was paid by the Issuer on September 29, 2015. These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of five limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These securities are held by Patricia Frost, Dr. Frost's spouse. Pursuant to Rule 16a-1(a)(4), the Reporting Person disclaims beneficial ownership of these shares. Represents the weighted average sales price for price increments ranging from $1.75 to $1.77. The Reporting Person undertakes to provide, upon request for the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of derivative securities sold at each separate price for all transaction reported on this Form 4. /s/ Phillip Frost, MD 2016-01-12 Frost Gamma Investments Trust by: /s/ Phillip Frost, MD, Trustee 2016-01-12 Frost Nevada Investments Trust by: /s/ Phillip Frost, MD, Trustee 2016-01-12